Stockreport

Navamedic Q2 and H1 2024: Stable growth continues and is supported by a new licensing and supply agreement [Yahoo! Finance]

ORION CORP NEW UNSP/ADR  (ORINY) 
PDF high-quality products to hospitals and pharmacies, delivered revenues of NOK 277.2 million , up 12.8 per cent from the corresponding period last year. Adjusted EBITA amo [Read more]